Fluid component analysis systems and methods for glucose monitoring and control

US8449524B2 · kind B2 · utility

Assignee

• OptiScan Biomedical Corporation · US

Inventors

• James R. Braig · Piedmont, US
• Richard Keenan · Livermore, US
• Peter Rule · Los Altos Hills, US
• Gil Rivas · Danville, US
• Mahesh Seetharaman · Danville, US

Key dates

• Filing date: Jun 30, 2011
• Grant date: May 28, 2013
• Expiry date: Jun 30, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61M2230/201
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.